TransMedics (TMDX) Raw Materials (2018 - 2026)

TransMedics has reported Raw Materials for 9 years, with the latest figure at $24.9 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials changed 0.07% year-over-year to $24.9 million; the trailing twelve-month figure through Mar 2026 stood at $24.9 million (changed 0.07% YoY), and the FY2025 full-year result was $26.2 million, down 6.34% from the prior year.
• Raw Materials for Q1 2026 stood at $24.9 million, down from $26.2 million in the prior quarter.
• The five-year high for Raw Materials was $28.0 million in Q3 2024, with the low at $8.3 million in Q1 2022.
• Average Raw Materials over 5 years is $19.7 million, with a median of $20.3 million recorded in 2025.
• Year-over-year, Raw Materials soared 136.06% in 2023 and tumbled 30.35% in 2025.
• Tracing TMDX's Raw Materials over 5 years: stood at $10.9 million in 2022, then soared by 136.06% to $25.8 million in 2023, then grew by 8.54% to $28.0 million in 2024, then slipped by 6.34% to $26.2 million in 2025, then dropped by 5.02% to $24.9 million in 2026.
• The last three Raw Materials figures came in at $24.9 million (Q1 2026), $26.2 million (Q4 2025), and $20.3 million (Q3 2025), per Business Quant data.

Peer Comparison